-
-
Call more information
660-596-2224 -
The FDA approved the New Drug Application for a meloxicam injection (Anjeso, Baudax Bio), which is indicated for managing moderate to severe pain, alone or in combination with other non–nonsteroidal anti-inflammatory drug (NSAID) analgesics, according to a press release from the company. The treatment is administered as a once-daily IV bolus push. It is the […]
Read MoreAuthor: Denise Baez Current smokers and people with chronic obstructive pulmonary disease (COPD) who contract coronavirus disease 2019 (COVID-19) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a study published in PLOS ONE. Jaber Alqahtani, University College London, London, United Kingdom, and colleagues scrutinised data from 15 studies comprising […]
Read MoreDG Alerts A clinical risk score can help clinicians identify patients with coronavirus disease 2019 (COVID-19) who may subsequently develop critical illness at the time of hospital admission, according to a study published in JAMA Internal Medicine. The tool, dubbed COVID-GRAM, uses 10 variables that are generally readily available at hospital admission to predict critical illness. […]
Read MoreBy Nancy Shaw DG News Treatment of chronic pain with spinal cord stimulation (SCS) therapy is linked to significant improvements in sleep quality, according to a study presented here at the 2020 Annual Meeting of the American Academy of Pain Medicine (AAPM). “Marked improvements in sleep quality were observed in the EVOKE study, with greater […]
Read MoreAuthors Judy George, Shannon Firth, and Kristina Fiore, MedPage Today Staff — Nearly 5% of those who responded to a bi-weekly MedPage Today survey have or had the disease Of 763 respondents in a MedPage Today survey — 86% of whom were physicians — 4.91% reported they had or currently have COVID-19. The findings come from […]
Read More